As of 2026-09-11, the EV/EBITDA ratio of Inari Medical Inc (NARI) is -138.50. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. NARI's latest enterprise value is 4,641.90 mil USD. NARI's TTM EBITDA according to its financial statements is -33.52 mil USD. Dividing these 2 quantities gives us the above NARI EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 9.6x - 12.2x | 10.1x |
| Forward P/E multiples | 10.9x - 15.6x | 13.0x |
| Fair Price | (5.54) - (6.26) | (5.91) |
| Upside | -106.9% - -107.8% | -107.4% |
| Date | EV/EBITDA |